Immediate Impact
55 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
2025 Standout
The landscape of small-molecule prodrugs
2024 Standout
Works of David Shamblaw being referenced
Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate
2019
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor–Based Single-Tablet Regimen for Initial HIV-1 Therapy
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| David Shamblaw | 338 | 238 | 140 | 7 | 374 | |
| Bruce Rashbaum | 336 | 234 | 134 | 9 | 379 | |
| Amanda Clarke | 316 | 213 | 131 | 6 | 393 | |
| Jeffrey L. Stephens | 288 | 185 | 159 | 15 | 424 | |
| Hiba Graham | 309 | 186 | 179 | 14 | 454 | |
| Marilyn McMurchie | 290 | 237 | 92 | 11 | 434 | |
| Elisabetta Chiesa | 303 | 240 | 95 | 17 | 347 | |
| Justin Koteff | 304 | 208 | 87 | 9 | 370 | |
| C. Tierney | 246 | 218 | 139 | 7 | 367 | |
| Bill Guyer | 412 | 316 | 99 | 11 | 439 | |
| Peter Cardiello | 371 | 277 | 70 | 13 | 417 |
All Works
Loading papers...